Michael Adam Gordon's Insider Trades & SAST Disclosures

Michael Adam Gordon's most recent trade in Lucid Diagnostics Inc was a trade of 300,000 Common stock done . Disclosure was reported to the exchange on Feb. 20, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Lucid Diagnostics Inc
Michael Adam Gordon General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 300,000 700,000 - 0 Common stock
Lucid Diagnostics Inc
Michael Adam Gordon General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 May 2024 400,000 400,000 - 0 Common stock
PAVmed Inc
Michael Adam Gordon General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 400,000 400,000 - - Employee stock option (right to buy)
Lucid Diagnostics Inc
Michael Adam Gordon General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 200,000 200,000 - - Employee stock option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades